CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-20 | Azoy Alexander Chief Accounting Officer | Returned to the company 10b5-1 | −68 | $18.21 | $1K | 10,220 |
| 2023-12-19 | Tang Carolyn C. General Counsel | Returned to the company 10b5-1 | −4,076 | $18.09 | $74K | 87,879 |
| 2023-12-19 | Nuyten Dimitry SA Chief Medical Officer | Returned to the company 10b5-1 | −1,540 | $18.09 | $28K | 71,195 |
| 2023-12-19 | Azoy Alexander Chief Accounting Officer | Returned to the company 10b5-1 | −661 | $18.09 | $12K | 10,288 |
| 2023-12-19 | Goeltz II Robert C. Chief Financial Officer | Returned to the company 10b5-1 | −2,808 | $18.09 | $51K | 53,835 |
| 2023-12-19 | Jarrett Jennifer Chief Operating Officer | Returned to the company 10b5-1 | −11,492 | $18.09 | $208K | 280,399 |
| 2023-12-19 | Jaen Juan C. President | Returned to the company 10b5-1 | −6,259 | $18.09 | $113K | 301,475 |
| 2023-12-19 | ROSEN TERRY J Chief Executive Officer | Returned to the company 10b5-1 | −14,000 | $18.09 | $253K | 3,866,526 |
| 2023-12-18 | Tang Carolyn C. General Counsel | Returned to the company 10b5-1 | −3,991 | $17.74 | $71K | 91,955 |
| 2023-12-18 | Nuyten Dimitry SA Chief Medical Officer | Returned to the company 10b5-1 | −1,507 | $17.74 | $27K | 72,735 |
| 2023-12-18 | Azoy Alexander Chief Accounting Officer | Returned to the company 10b5-1 | −647 | $17.74 | $11K | 10,949 |
| 2023-12-18 | Goeltz II Robert C. Chief Financial Officer | Returned to the company 10b5-1 | −2,749 | $17.74 | $49K | 56,643 |
| 2023-12-18 | Jarrett Jennifer Chief Operating Officer | Returned to the company 10b5-1 | −11,250 | $17.74 | $200K | 291,891 |
| 2023-12-18 | Jaen Juan C. President | Returned to the company 10b5-1 | −6,128 | $17.74 | $109K | 307,734 |
| 2023-12-18 | ROSEN TERRY J Chief Executive Officer | Returned to the company 10b5-1 | −13,705 | $17.74 | $243K | 3,880,526 |
| 2023-12-01 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −282 | $14.95 | $4K | 11,596 |
| 2023-09-22 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −21,369 | $19.99 | $427K | 302,691 |
| 2023-09-18 | Nuyten Dimitry SA Chief Medical Officer | Returned to the company 10b5-1 | −3,708 | $20.40 | $76K | 73,591 |
| 2023-09-18 | Jarrett Jennifer Chief Operating Officer | Returned to the company 10b5-1 | −12,506 | $20.40 | $255K | 324,060 |
| 2023-07-28 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −45,000 | $20.25 | $911K | 336,566 |
Page 10 of 20 · 381 trades